GSH protects against oxidative stress and toxicity in VL-17A cells exposed to high glucose

European Journal of Nutrition

Volumn 54, Issue 2, 2015, Pages 223-234

  Kumar, S Mathan ^a   Swaminathan, Kavitha ^a   Clemens, Dahn L ^b,c   Dey, Aparajita ^a  

^a ANNA UNIVERSITY   (India)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Glutathione; Hyperglycemia; Injury; Liver; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ALCOHOL DEHYDROGENASE; ANTIMETABOLITE; ANTIOXIDANT; BUTHIONINE SULFOXIMINE; CYTOCHROME P450 2E1; GLO1 PROTEIN, HUMAN; GLUCOSE; GLUTATHIONE; LACTOYLGLUTATHIONE LYASE; MALEIC ACID DERIVATIVE; MALEIC ACID DIETHYL ESTER; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; URSODEOXYCHOLIC ACID;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL CLONE; CELL SURVIVAL; DRUG EFFECTS; GENETICS; HEPG2 CELL LINE; HUMAN; HYPERGLYCEMIA; LIVER CELL; METABOLISM; OXIDATIVE STRESS;

ACETYLCYSTEINE; ALCOHOL DEHYDROGENASE; ANTIMETABOLITES; ANTIOXIDANTS; APOPTOSIS; BUTHIONINE SULFOXIMINE; CELL SURVIVAL; CLONE CELLS; CYTOCHROME P-450 CYP2E1; GLUCOSE; GLUTATHIONE; HEP G2 CELLS; HEPATOCYTES; HUMANS; HYPERGLYCEMIA; LACTOYLGLUTATHIONE LYASE; MALEATES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; URSODEOXYCHOLIC ACID;

EID: 84939872032     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0703-2     Document Type: Article

References (49)

1. Cederbaum AI, Lu Y, Wu D (2009) Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 83(6):519–548
2. West IC (2000) Radicals and oxidative stress in diabetes. Diabet Med 17(3):171–180
3. Chandrasekaran K, Swaminathan K, Kumar SM, Clemens DL, Dey A (2012) In vitro evidence for chronic alcohol and high glucose mediated increased oxidative stress and hepatotoxicity. Alcohol Clin Exp Res 36(6):1004–1012
4. Chandrasekaran K, Swaminathan K, Kumar SM, Clemens DL, Dey A (2012) Increased oxidative stress and toxicity in ADH and CYP2E1 overexpressing human hepatoma VL-17A cells exposed to high glucose. Integr Biol 4(5):550–563
5. Swaminathan K, Kumar SM, Clemens DL, Dey A (2013) Chronic ethanol and high glucose inducible CYP2E1 mediated oxidative stress leads to greater cellular injury in VL-17A cells: a potential mechanism for liver injury due to chronic alcohol consumption and hyperglycemia. Toxicol Res 2:245–258
6. Ghibelli L, Fanelli C, Rotilio G, Lafavia E, Coppola S, Colussi C, Civitareale P, Ciriolo MR (1998) Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J 12(6):479–486
7. Lu SC (1999) Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 13(10):1169–1183
8. Lu SC, Ge JL, Huang HY, Kuhlenkamp J, Kaplowitz N (1993) Thiol-disulfide effects on hepatic glutathione transport. Studies in cultured rat hepatocytes and perfused livers. J Clin Invest 92(3):1188–1197
9. Yuan L, Kaplowitz N (2009) Glutathione in liver diseases and hepatotoxicity. Mol Asp Med 30(1–2):29–41
10. Huang ZZ, Chen C, Zeng Z, Yang H, Oh J, Chen L, Lu SC (2001) Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. FASEB J 15(1):19–21
11. Griffith OW, Meister A (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 254(16):7558–7560
12. Deneke SM, Fanburg BL (1989) Regulation of cellular glutathione. Am J Physiol 257(4 Pt 1):L163–L173
13. Griffith OW, Anderson ME, Meister A (1979) Inhibition of glutathione biosynthesis by prothionine sulfoximine (S-n-propyl homocysteine sulfoximine), a selective inhibitor of gamma-glutamylcysteine synthetase. J Biol Chem 254(4):1205–1210
14. Plummer JL, Smith BR, Sies H, Bend JR (1981) Chemical depletion of glutathione in vivo. Methods Enzymol 77:50–59
15. Boyland E, Chasseaud LF (1967) Enzyme-catalysed conjugations of glutathione with unsaturated compounds. Biochem J 104(1):95–102
16. Estrela JM, Sáez GT, Such L, Viña J (1983) The effect of cysteine and N-acetyl cysteine on rat liver glutathione (GSH). Biochem Pharmacol 32(22):3483–3485
17. Mitsuyoshi H, Nakashima T, Sumida Y, Yoh T, Nakajima Y, Ishikawa H, Inaba K, Sakamoto Y, Okanoue T, Kashima K (1999) Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem Biophys Res Commun 263(2):537–542
18. Donohue TM, Osna NA, Clemens DL (2006) Recombinant HepG2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity. Int J Biochem Cell Biol 38(1):92–101
19. Chandrasekaran K, Swaminathan K, Chatterjee S, Dey A (2010) Apoptosis in HepG2 cells exposed to high glucose. Toxicol Vitr 24(2):387–396
20. Marí M, Cederbaum AI (2000) CYP2E1 Overexpression in HepG2 cells induces glutathione synthesis by transcriptional activation of g-glutamylcysteine synthetase. J Biol Chem 275(20):15563–15571
21. Hassan AS, Bunick D, Lund LA, Bottje WG (1992) Glutathione and bile acid synthesis. Effect of GSH content of HepG2 cells on the activity and mRNA levels of cholesterol 7 alpha-hydroxylase. Biochem Pharm 44(7):1475–1477
22. Osna NA, Clemens DL, Donohue TM Jr (2005) Ethanol metabolism alters interferon gamma signaling in recombinant HepG2 cells. Hepatology 42(5):1109–1117
23. Wu D, Cederbaum AI (1996) Ethanol cytotoxicity to a transfected hepg2 cell line expressing human cytochrome P4502E1. J Biol Chem 271(39):23914–23919
24. Dey A, Cederbaum AI (2006) Geldanamycin, an inhibitor of Hsp90, potentiates cytochrome P4502E1-mediated toxicity in HepG2 cells. J Pharmacol Exp Ther 317(3):1391–1399
25. Palmeira CM, Rolo AP, Berthiaume J, Bjork JA, Wallace KB (2007) Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis. Toxicol Appl Pharmacol 225(2):214–220
26. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27(3):502–522
27. Di Ilio C, Angelucci S, Pennelli A, Zezza A, Tenaglia R, Sacchetta P (1995) Glyoxalase activities in tumor and non-tumor human urogenital tissues. Cancer Lett 96(2):189–193
28. Baba SP, Barski OA, Ahmed Y, O’Toole TE, Conklin DJ, Bhatnagar A, Srivastava S (2009) Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue. Diabetes 58(11):2486–2497
29. Palanisamy GS, Kirk NM, Ackart DF, Shanley CA, Orme IM, Basaraba RJ (2011) Evidence for oxidative stress and defective antioxidant response in guinea pigs with tuberculosis. PLoS ONE 6(10):e26254
30. Handl M, Filová E, Kubala M, Lánský Z, Kolácná L, Vorlícek J, Trc T, Pach M, Amler E (2007) Fluorescent advanced glycation end products in the detection of factual stages of cartilage degeneration. Physiol Res 56(2):235–242
31. Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, Matsuoka TA, Matsuhisa M, Yamasaki Y (2007) Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal 9(3):355–366
32. Kim SK, Woodcroft KJ, Khodadadeh SS, Novak RF (2004) Insulin signaling regulates gamma-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. J Pharmacol Exp Ther 311(1):99–108
33. Swaminathan K, Kumar SM, Clemens DL, Dey A (2013) Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 over-expressing VL-17A cells. Biochim Biophys Acta 1830(10):4407–4416
34. Mårtensson J, Jain A, Stole E, Frayer W, Auld PA, Meister A (1991) Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress(ascorbate/mitochondria/antioxidants/buthionine sulfoximine/glutathione ester). Proc Natl Acad Sci USA 88(20):9360–9364
35. Sun L, Gu L, Wang S, Yuan J, Yang H, Zhu J, Zhang H (2012) N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity. PLoS ONE 7(3):e32503
36. Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15(1):7–10
37. Langer C, Jürgensmeier JM, Bauer G (1996) Reactive oxygen species act at both TGF-beta-dependent and -independent steps during induction of apoptosis of transformed cells by normal cells. Exp Cell Res 222(1):117–124
38. Hug H, Enari M, Nagata S (1994) No requirement of reactive oxygen intermediates in Fas-mediated apoptosis. FEBS Lett 351(3):311–313
39. Raza H, John A (2012) Implications of altered glutathione metabolism in aspirin-induced oxidative stress and mitochondrial dysfunction in HepG2 cells. PLoS ONE 7(4):e36325
40. Lu C, Armstrong JS (2007) Role of calcium and cyclophilin D in the regulation of mitochondrial permeabilization induced by glutathione depletion. Biochem Biophys Res Commun 363(3):572–577
41. Tan KS, Lee KO, Low KC, Gamage AM, Liu Y, Tan GY, Koh HQ, Alonso S, Gan YH (2012) Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest 122(6):2289–2300
42. Iwata K, Nishinaka T, Matsuno K, Kakehi T, Katsuyama M, Ibi M, Yabe-Nishimura C (2007) The activity of aldose reductase is elevated in diabetic mouse heart. J Pharmacol Sci 103(4):408–416
43. Gülen S, Dinçer S (2007) Effects of leptin on oxidative stress in healthy and Streptozotocin-induced diabetic rats. Mol Cell Biochem 302(1–2):59–65
44. Di Ilio C, Angelucci S, Pennelli A, Zezza A, Tenaglia R, Sacchetta P (1995) Glyoxalase activities in tumor and non-tumor human urogenital tissues. Cancer Lett 96(2):189–193
45. Kumar SM, Swaminathan K, Clemens DL, Dey A (2014) Modulation of GSH with exogenous agents leads to changes in glyoxalase 1 enzyme activity in VL-17A cells exposed to chronic alcohol plus high glucose. Food Funct 5(2):345–358
46. Skapare E, Konrade I, Liepinsh E, Strele I, Makrecka M, Bierhaus A, Lejnieks A, Pirags V, Dambrova M (2013) Association of reduced glyoxalase1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients. J Diabetes Complic 27(3):262–267
47. Phillips SA, Mirrlees D, Thornalley PJ (1993) Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil. Biochem Pharmacol 46(5):805–811
48. Townsend DM (2007) S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 7(6):313–324
49. Sampathkumar R, Balasubramanyam M, Sudarslal S, Rema M, Mohan V, Balaram P (2005) Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy. Clin Biochem 38(10):892–899